| #130 |
Pierre Emeric |
Abbott |
1 |
| #130 |
Howard A. Stone |
Princeton University |
1 |
| #130 |
Bob Horvath |
R.J. Reynolds Tobacco |
1 |
| #130 |
Min Ge |
Princeton University |
1 |
| #130 |
Jesus M. Dones |
MIT |
1 |
| #130 |
Tamar Rosenbaum |
Bristol-Myers Squibb |
1 |
| #130 |
Jill Sherwood |
Pearl Therapeutics |
1 |
| #130 |
Carol J. Buck |
Unknown |
1 |
| #130 |
Benedetto FARSACI |
Bristol-Myers Squibb |
1 |
| #130 |
Wenying Jian |
Johnson & Johnson |
1 |
| #130 |
Seung Hwan Baek |
Samsung |
1 |
| #130 |
Katy Lynn Simonsen |
Bristol-Myers Squibb |
1 |
| #130 |
Joshua D. Rabinowitz |
Alexza Pharmaceuticals |
1 |
| #130 |
Clay Byers |
Princeton University |
1 |
| #130 |
Raghuraman Govindaraj |
— |
1 |
| #130 |
Benjamin J. Glasser |
Rutgers, The State University Of New Jersey |
1 |
| #130 |
Sridhar Seetharaman |
Bank of America |
1 |
| #130 |
Jingtao Jonathan Yan |
The Dun & Bradstreet |
1 |
| #130 |
Paul Andrew BASCIANO |
Bristol-Myers Squibb |
1 |
| #130 |
Xiaoliang Dai |
Princeton University |
1 |
| #130 |
Sanskar Sahay |
Experian Information Solutions |
1 |
| #130 |
Michael Burns |
Rolls-Royce Plc |
1 |
| #130 |
Peter Riebel |
Dsm Ip Assets B.V. |
1 |
| #130 |
Ruby B. Lee |
— |
1 |
| #130 |
Anuradha Somani |
U.S. Bancorp, National Association |
1 |
| #130 |
Meytal B. Higgins |
ExxonMobil |
1 |
| #130 |
James Herschel Gryphon Shafer |
— |
1 |
| #130 |
Iksoo Chun |
Johnson & Johnson |
1 |
| #130 |
Michael Heilman |
Educational Testing Service |
1 |
| #130 |
Sebastian Seung |
Princeton University |
1 |
| #130 |
Chakrakodi Vishnu Shastry |
Dialight |
1 |
| #130 |
Jill Burstein |
— |
1 |
| #130 |
Siva Sandeep Dhandu |
Verizon |
1 |
| #130 |
Bachir El Khadir |
Google |
1 |
| #130 |
Deborah L. Lynch |
— |
1 |
| #130 |
Sha Ha |
Bayer Healthcare |
1 |
| #130 |
Eric Cosatto |
AT&T |
1 |
| #130 |
Olga G. Troyanskaya |
Princeton University |
1 |
| #130 |
Jonathan Sporn |
Sk Biopharmaceuticals Co. |
1 |
| #130 |
Anthony M. Agnello |
Eventide |
1 |
| #130 |
Andrew John Bruno Naumann zu Koenigsbrueck |
Visa |
1 |
| #130 |
Sergei Kolotuchin |
Bristol-Myers Squibb |
1 |
| #130 |
Raul Rabadan |
Columbia University |
1 |
| #130 |
Kumar Ramaswamy |
Thomson Licensing |
1 |
| #130 |
Jean E. Schwarzbauer |
Princeton University |
1 |
| #130 |
Amir Tamrakar |
Sri International |
1 |
| #130 |
Jenny H. Xie |
Bristol-Myers Squibb |
1 |
| #130 |
A. James Link |
— |
1 |
| #130 |
Mahmoud Mostapha |
Siemens Healthineers Ag |
1 |
| #130 |
Jiming Shi |
Spotify Ab |
1 |